Panagiotis Dimitriou

Dr. Panagiotis Dimitriou


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Metabolism
Verified
Journal Article
Closed access
Konstantinos TziomalosKonstantinos Tziomalos
Konstantinos Tziomalos
PDPanagiotis Dimitriou
Panagiotis Dimitriou
SBStella D. Bouziana
Stella D. Bouziana
MSMarianna Spanou
Marianna Spanou
SKStavroula Kostaki
Stavroula Kostaki
AHApostolos I. Hatzitolios
Apostolos I. Hatzitolios

29 April 2020 in Atmosphere
Verified
Journal Article
Open access
PDF file
ECEirini Christaki
Eirini Christaki
PDPanagiotis Dimitriou
Panagiotis Dimitriou
KPKaterina Pantavou
Katerina Pantavou
Georgios NikolopoulosGeorgios Nikolopoulos
Georgios Nikolopoulos
Water ecosystems can be rather sensitive to evolving or sudden changes in weather parameters. These changes can result in alterations in the natural habitat of pathogens, vectors, and human hosts, as well as in the transmission dynamics and geographic distribution of infectious agents. However, the interaction between climate change and infectious disease is rather complicated and not deeply understood. In this narrative review, we discuss climate-driven changes in the epidemiology of Vibrio species-associated diseases with an emphasis on cholera. Changes in environmental parameters do shape the epidemiology of Vibrio cholerae. Outbreaks of cholera cause significant disease burden, especially in developing countries. Improved sanitation systems, access to clean water, educational strategies, and vaccination campaigns can help control vibriosis. In addition, real-time assessment of climatic parameters with remote-sensing technologies in combination with robust surveillance systems could help detect environmental changes in high-risk areas and result in early public health interventions that can mitigate potential outbreaks.

11 July 2019 in Brain Injury
Verified
Journal Article
Closed access
PDPanagiotis Dimitriou
Panagiotis Dimitriou
KTKonstantinos Tziomalos
Konstantinos Tziomalos
KCKonstantinos Christou
Konstantinos Christou
SKStavroula Kostaki
Stavroula Kostaki
SAStella-Maria Angelopoulou
Stella-Maria Angelopoulou
AHApostolos I. Hatzitolios
Apostolos I. Hatzitolios
Background and aims: Pre-hospital delay is a crucial factor that determines the eligibility for intravenous thrombolysis in patients with acute ischemic stroke. We aimed to evaluate the time to presentation at the emergency department (ED) and the factors that affect this time. Patients and methods: We prospectively studied 682 patients who were admitted with acute ischemic stroke (43.3% men, age 79.9 ± 6.6 years). Results: The median time to presentation at the ED was 2.1 h (range 0.15 to 168 h); 68.8% of the patients arrived within 4.5 h and 56.5% arrived within 3 h from the onset of symptoms. Independent predictors of presentation within 4.5 h were the use of emergency medical services (EMS) for transportation to the hospital (OR 2.61, 95% CI 1.38–4.94, p = .003), family history of cardiovascular disease (CVD)(OR 4.0 0,95%CI 1.61–12.23, p = .006) and the absence of history of smoking (OR 2.49, 95% CI 1.13–5.42, p = .021). Independent predictors of presentation within 3 h were the use of EMS for transportation to the hospital (OR 6.24, 95% CI 2.52–16.63, p = .0001), family history of CVD (OR 3.07, 95% CI 1.14–9.43, p = .03), and a moderately severe stroke at admission (OR vs. minor stroke 0.38, 95% CI 0.16–0.87, p = .02). Conclusions: A considerable proportion of patients with acute ischemic stroke arrives at the ED after the 4.5-h threshold for performing intravenous thrombolysis. Non-smokers, patients with a family history of CVD, with moderately severe stroke and those who use the EMS are more likely to arrive on time.

25 October 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
ATAndreas George Tofarides
Andreas George Tofarides
PDPanagiotis Dimitriou
Panagiotis Dimitriou
Georgios NikolopoulosGeorgios Nikolopoulos
Georgios Nikolopoulos
DRDimitrios Rogkas
Dimitrios Rogkas
CFChristina Flourou
Christina Flourou
ECEirini Christaki
Eirini Christaki
Klebsiella pneumoniae is one of the leading causes of nosocomial infections. It has been estimated that nosocomial infection by Klebsiella pneumoniae comprises 3–8% of all nosocomial infections. Klebsiella pneumoniae bloodstream infections (BSIs) occur worldwide with varying mortality. Resistant strains, like those producing extended-spectrum beta-lactamases (ESBL) and carbapenemases, are becoming increasingly common, especially in hospital settings, posing therapeutic challenges. In this article, we aimed to study the epidemiology and risk factors of BSIs due to resistant Klebsiella pneumoniae strains in the period 1 January 2014–31 December 2018 at the Nicosia General Hospital, the largest tertiary hospital in Cyprus. Data on demographics, co-morbidities, prior hospitalization, prior intensive care unit (ICU) admission, previous antimicrobial use, nosocomial acquisition of the infection, the presence of a prosthetic device or surgery, and the primary site of infection were retrospectively recorded. Associations between the detection of ESBL Klebsiella pneumoniae BSIs and factors/covariates were examined using logistic regression. This study involved 175 patients with BSI caused by Klebsiella pneumoniae. Of these, 61 BSIs were caused by ESBL strains, 101 by non-ESBL, and 13 by carbapenem-resistant (CR) strains. In univariable analyses, age, sex, heart disease, antimicrobial use during current admission, previous hospitalization (ward or ICU), and primary BSI were associated with the presence of an ESBL strain. Antibiotic use during current admission and heart disease remained statistically significantly associated with ESBL Klebsiella pneumoniae BSI in multivariable models. Antibiotic use during current admission, respiratory infection, and a recent history of surgery were more prevalent among CR Klebsiella pneumoniae BSI patients than among non-CR Klebsiella pneumoniae BSI patients. Our study showed that recent antimicrobial use and heart disease were associated with BSI due to ESBL-producing Klebsiella pneumoniae. This finding could inform clinical practice in hospital settings.

23 November 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
PDPanagiotis Dimitriou
Panagiotis Dimitriou
Georgios NikolopoulosGeorgios Nikolopoulos
Georgios Nikolopoulos
MKMaria Koliou
Maria Koliou
ECElisavet Constantinou
Elisavet Constantinou
CAChara Azina
Chara Azina
ECEirini Christaki
Eirini Christaki
Background: Outbreaks of acute hepatitis A (AHA) have recently been reported in Europe among men who have sex with men (MSM). The aim of this work was to evaluate, for the first time, trends in the reported cases of AHA in Cyprus over the last seven years. Methods: We retrospectively studied all people reported with AHA in Cyprus between January 2013 and December 2019. Demographic data, type of transmission, vaccination status for HAV, laboratory and clinical data were analyzed. Results: The asnalysis involved 33 AHA cases (age 32.7 ± 17.4 years, 78.8% males). An increase in AHA reports was observed between July 2017 and June 2018 when more than a third (n = 13) of the cases of the period 2013–2019 were reported. The reporting rate of AHA doubled from 0.52 cases per 100,000 population (before July 2017) to 1.12 cases per 100,000 population (July 2017–June 2018). The male/female (M/F) ratio increased from one in 2013 to eight in 2018. Conclusion: An increase in AHA reports occurred in Cyprus between July 2017 and June 2018. Many cases with AHA in that period were MSM. Enhanced surveillance and timely public health interventions, like vaccination and awareness promotion, are important for preventing future outbreaks.

1 January 2016 in European Journal of Case Reports in Internal Medicine
Verified
Journal Article
Open access
PDF file
AIAntreas Iacovou Ioannou
Antreas Iacovou Ioannou
DDDimitra Dimitriou
Dimitra Dimitriou
PDPanagiotis Dimitriou
Panagiotis Dimitriou
AKAram Katsios
Aram Katsios
GPGeorgios Petrikkos
Georgios Petrikkos
Complicated Lemierre Syndrome Caused by Streptococcus gordonii and Possible Rickettsial Co-Infection in a Patient with Thrombophilia Predisposition